Carlos Camps

Participative design of a support questionnaire for the process of diagnosing anorexia-caquexia syndorme (ACS) in cancer patients

V. Valentin, A. Casas, J. Carulla, 2007 .

Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.

Rafael Sirera, Carlos Camps, R. Bremnes, 2006, Lung cancer.

Phase II Study of Sunitinib in Patients with Non-small Cell Lung Cancer and Irradiated Brain Metastases

Carlos Camps, G. Scagliotti, S. Novello, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The role of the clinical research coordinator – data manager – in oncology clinical trials

Carlos Camps, Rafael Rosell, R. Rosell, 2004, BMC medical research methodology.

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer

Miguel Angel Molina, Bartomeu Massuti, Carlos Camps, 2010, Journal of Translational Medicine.

Passenger mutations in cancer evolution

Ana Blasco, Silvia Calabuig-Fariñas, Eloisa Jantus-Lewintre, 2019 .

The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

Rafael Sirera, Carlos Camps, T. Dønnem, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Screening for epidermal growth factor receptor mutations in lung cancer.

Mariano Provencio, Miguel Angel Molina, Bartomeu Massuti, 2009, The New England journal of medicine.

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer

Eduardo Andrés-León, Ana Salinas, Eloisa Jantus-Lewintre, 2016, Oncotarget.

The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer

Rafael Sirera, Carlos Camps, T. Dønnem, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Trabectedin in patients with advanced non-small-cell lung cancer (NSCLC) with XPG and/or ERCC1 overexpression and BRCA1 underexpression and pretreated with platinum.

Antonio Nieto, Mariano Provencio, Bartomeu Massuti, 2012, Lung cancer.

Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2.

Rafael de Cid, David Torrents, Lauro Sumoy, 2018, Cancer treatment and research communications.